AstraZeneca PLC
AstraZeneca PLC (NYSE: AZN) is trading at $161.47, about ₹15,501 at today's USD/INR rate, as of 30 Sep 2026, 4:00 PM ET, down 1.67% today. Indian residents can buy AstraZeneca from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$161.47
Today's high
$164.48
52 week low
$153.41
52 week high
$212.71
AZN opened at $164.47, closed previously at $164.21, and has traded between $153.41 and $212.71 over the past 52 weeks.
About
AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and oncological conditions. Furthermore, it provides essential solutions for COVID-19 and various rare diseases, with products like Vaxzevria and Soliris. AstraZeneca engages with primary and specialty care physicians worldwide, facilitating distribution through a robust network of representatives and local offices across the United Kingdom, continental Europe, the Americas, Asia, Africa, and Australasia. The firm actively drives innovation through strategic collaborations, partnering with entities such as Neurimmune AG for the development and commercialization of NI006, BenevolentAI for systemic lupus erythematosus drug discovery, Lunit for AI-powered digital pathology risk assessment in NSCLC, and Absci Corporation for AI-driven oncology target identification. Founded in 1992, the company was initially known as Zeneca Group PLC, subsequently rebranding to AstraZeneca PLC in April 1999, and maintains its headquarters in Cambridge, United Kingdom.
Key statistics
Avg. volume
2.99M
Market cap
$250.42B
P/E Ratio
24.28
Price-to-sales ratio
4.12
Enterprise value
$296.02B
Free cash flow yield
3.19%
Debt-to-equity ratio
0.64
Return on equity
21.07%
ROIC
13.03%
Beta
0.21
Dividend yield
1.95%
Last dividend
$3.23
Financial overview
Revenue
$58.74B
Earnings per share
$6.60
Free cash flow
$8.67B
Net profit margin
17.02%
Gross margin
79.27%
EBITDA
$19.83B
Revenue growth
8.63%
Similar securities
This is not an investment recommendation
How to buy AstraZeneca from India
Indian residents can buy AstraZeneca shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for AstraZeneca and place an order
Find AstraZeneca by name or by its ticker, AZN, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. AstraZeneca trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your AstraZeneca position in USD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in AstraZeneca from India
Trading and taxes when buying AstraZeneca from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. AstraZeneca’s current yield is 1.95%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy AstraZeneca stock?
Yes. AstraZeneca (AZN) has been listed on the New York Stock Exchange since 1993, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one AstraZeneca share cost in rupees?
One AstraZeneca share is $161.47 — about ₹15,501 at a USD/INR rate of 96.00 on 30 Sep 2026. Both the AstraZeneca price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying AstraZeneca from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy AstraZeneca with less than the price of one share?
Yes. A whole AstraZeneca share is $161.47, but there is no minimum trade size: you enter a rupee or dollar amount and receive the matching fraction.
How are gains on AstraZeneca shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the AstraZeneca price. Paasa issues a capital-gains statement for your return.
Does AstraZeneca pay a dividend, and how is it taxed in India?
Yes. AstraZeneca pays a dividend and the current yield is 1.95%; the last declared dividend was $3.23 per share, about ₹310.08. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade AstraZeneca from India?
The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is AstraZeneca a United States company, and does that change how it is taxed?
AstraZeneca trades on the New York Stock Exchange in US dollars, but the company is domiciled in United Kingdom. AstraZeneca trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.
Do I have to declare AstraZeneca shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your AstraZeneca holding, its cost and its closing value.
How do I sell AstraZeneca and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.